| pubmed-article:8487171 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8487171 | lifeskim:mentions | umls-concept:C0023319 | lld:lifeskim |
| pubmed-article:8487171 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:8487171 | lifeskim:mentions | umls-concept:C0596177 | lld:lifeskim |
| pubmed-article:8487171 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:8487171 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8487171 | pubmed:dateCreated | 1993-6-7 | lld:pubmed |
| pubmed-article:8487171 | pubmed:abstractText | A prospective in vivo study of 50 intraocular lenses was done to document the long-term results and biocompatibility of heparin-surface-modified poly(methyl methacrylate) posterior chamber lenses. Continuous curvilinear capsulorhexis and phacoemulsification were performed throughout and examinations were by slit-lamp and specular microscopy. Decentrations of more than 1 mm were seen in 4% of eyes. Stress folds from the haptic traction forces were detected in 16%. A posterior capsulotomy was performed in 10% because of fibrosis or Elschnig pearl formation. Fine fibers were found on the lens surface in 76%. During the first postoperative days only a moderate number of fibroblast-like cells was observed. Foreign-body giant cells were seen in 8%. All cases with foreign-body giant cells had posterior synechias. Visual performance and clinical results were comparable to those of other well-approved intraocular lenses. The low percentage of cellular reaction on the lens surface suggests good biocompatibility. | lld:pubmed |
| pubmed-article:8487171 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8487171 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8487171 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8487171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8487171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8487171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8487171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8487171 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8487171 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:8487171 | pubmed:issn | 0886-3350 | lld:pubmed |
| pubmed-article:8487171 | pubmed:author | pubmed-author:AmouTT | lld:pubmed |
| pubmed-article:8487171 | pubmed:author | pubmed-author:MenapaceRR | lld:pubmed |
| pubmed-article:8487171 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8487171 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:8487171 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8487171 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8487171 | pubmed:pagination | 258-62 | lld:pubmed |
| pubmed-article:8487171 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:meshHeading | pubmed-meshheading:8487171-... | lld:pubmed |
| pubmed-article:8487171 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8487171 | pubmed:articleTitle | Long-term results and biocompatibility of heparin-surface-modified intraocular lenses. | lld:pubmed |
| pubmed-article:8487171 | pubmed:affiliation | 1. Universität Augenklinik Wien, Vienna, Austria. | lld:pubmed |
| pubmed-article:8487171 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8487171 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8487171 | lld:pubmed |
